Immunogenicity Assay Assessment

Newly developed biologics, including biosimilars, bispecifics, and antibody drug conjugates, have unique features and require a specific skill set. To continue pushing safe and efficacious products to patients, researchers must adapt. At the Ninth Annual Strategies for Immunogenicity Assay Assessment, industry experts will deliver case studies and critical insight into development, optimization, and validation of immunogenicity assays. This event will address proactive strategies for managing off-target toxicity and mitigating risks from concept to product.
Topics may include but are not limited to:

  • Assays including:
    • Neutralizing antibody assays
    • ADA assays
    • Forced release assays
    • Confirmatory assays

  • Specificity testing for entire molecules
  • Considerations for antibody drug conjugates and bispecifics
  • nAb assay transfer
  • Development, optimization, and validation of assays
  • Characterizing ADA responses
  • Multiplexing immunogenicity assays
  • Immunogenicity assay correlation with clinical findings
  • Cutpoint determination
  • Interpretation of drug interference
  • Overcoming target interference
  • Non-clinical testing: Understanding clinical relevance

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

The deadline for submission is Friday, September 25, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Samantha Drinkwater
Conference Producer
T: 781-972-5461

Jason Gerardi
(Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452

Carol Dinerstein
(Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471